May 13th, 2022
Sunday
17:00
GMT
Free
Registration is required
Certification
To all attendants via email
“May 13th, 2022 at 17:00 GMT”
New York
13:00
London
18:00
Athens
20:00
San Diego
10:00
CEST/Paris, Rome
19:00
Beijing
01:00 (11/04)
The Webinar continues the series of MSc Webinars – the online-ZOOM events for the clinicians and educators in the field of psychiatry.
The MSc Webinar is organized for mental health professionals by the Faculty of Medicine, School of Health Sciences and Medical School of the Aristotle University of Thessaloniki, under the auspices of:
WPA 2020-23 Action Plan group on Evidence Based Psychopharmacology
WPA section on Evidence Based Psychiatry
The aim of these educational sessions is to provide a global and comprehensive update of the newest developments in neurobiology, psychopharmacology, treatment guidelines and personcentered care of mental disorders.
The strategic approach of the invited speakers is to avoid content-free eloquence and authority and to face hard questions on the base of research findings.
SPEAKERS
Prof. Guy Goodwin
"Psychedelic drugs and psychiatry: Back to the future?"
Guy Goodwin, DPhil, FMedSci is CMO, Compass pathways. He is Emeritus Professor of Psychiatry at the University of Oxford, Oxford, UK. He completed his medical degree and DPhil in physiology at the University of Oxford and, following training in psychiatry, became a Clinical Scientist and Consultant Psychiatrist at the MRC Brain Metabolism Unit at the Royal Edinburgh Hospital, Edinburgh, UK.
His research interests have been in the treatment of bipolar disorder and the application of neuroscience in understanding the neurobiology of mood disorders, with a focus on developing new treatments. His current interest is the potential to transform treatment using new technology and new drugs, notably the psychedelics.
He is a Fellow of the American College of Neuropsychopharmacology, and has previously held the position of President of the British Association for Psychopharmacology (2004–2005). He is past president of the European College of Neuropsychopharmacology (ECNP) and Emeritus Senior Investigator on the faculty of UK National Institute for Health Research (NIHR). He is a Thomson Reuters highly cited researcher (top 1% in field).
Prof. Robert Cloninger
"The Genetics and Psychobiology of Personality & Well-being"
Claude Robert Cloninger, MD, PhD is Distinguished Life Fellow of APA, Director of the Anthropedia Institute, and Professor Emeritus of Psychiatry at Washington University in St. Louis.
He is widely cited and honored for his biopsychosocial research on personality, psychopathology, and health. He has received the Adolf Meyer, Judd Marmor, and Oskar Pfister Awards from the APA, lifetime achievement awards in Psychiatric Genetics and Addiction Medicine, and is a member of the National Academy of Medicine USA. Dr. Cloninger has published ten books and over 600 articles in psychiatry, psychology, and genetics.
Cloninger is best known for his pioneering research in the genetics and neurobiology of personality and personality disorders. He has developed two widely used tools for measuring personality: the Temperament and Character Inventory (TCI) and the Tridimensional Personality Questionnaire.
Organization
MSC ‘CLINICAL MENTAL HEALTH’
SCHOOL OF MEDICINE
FACULTY OF HEALTH SCIENCES
ARISTOTLE UNIVERSITY OF THESSALONIKI GREECE
In collaboration with
WPA 2020-23 Action Plan group on Evidence Based Psychopharmacology
WPA section on Evidence Based Psychiatry
